Vienna, 13.02.2009
In Austria approximately 5,200 people are diagnosed with colonic cancer per year and around 2,700 die of it. Worldwide approximately 1.23 million people are diagnosed with colonic cancer per year and around 529,000 die of it. (Source www.dep-iarc.fr).
Prof. Ludwig, a sworn expert court witness regarded the life of a female patient who had been diagnosed with a metastasising colorectal carcinoma on 17.5.1988 (letter from Helmut Jakob to Spiegel, operation report) as "not acutely threatened". (12 May 1997) When he was presented with the same medical history (provided with different names) he judged these factors to be an "unfavourable prognosis". His commentary on the case which he describes as hopeless: "Your acquaintance is in a condition after operation on an ulcerating adenocarcinoma of the large intestine, which has already produced lymph node metastases. The size of the primary tumour is striking, the fact that it was already ulcerated and furthermore the bad differentiation. These factors point to an unfavourable prognosis." (12 July 1999)
The patient is still alive today – more than 20 years later – because Dr. Nowicky made Ukrain available to her free of charge. Ms. Jakob had paid her insurance contributions all her life to state and even private health insurance companies. Despite this she was let down by the insurance institutions in times of need.
The main preparation for chemotherapy for colonic cancer is 5-Fluorouracil (5-FU, NSC 19893), a highly toxic product with some serious side-effects, which is mostly used in various combinations. In tests carried out as part of the National Cancer Institute Developmental Therapeutics Program (NCI DTP) the dose-reaction curves for 5-FU showed only growth inhibition for 8 human colonic cancer cell lines (Source dtp.nci.nih.gov). A lethal effect on these cell lines was not achieved with 5-FU but nevertheless the anti-cancer effect of this medicament was evaluated as outstanding by the NCI. In contrast to this NSC 631570, which demonstrates no toxic side-effects in therapeutic doses, showed an almost 100% lethal effect on the same 8 colonic cancer cell lines (Ukrain: results of preclinical and clinical studies).
Deutsch
English